These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37835574)

  • 1. Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
    Tam OCH; Ho RSL; Chan S; Li KKW; Lam TL; Cheung ETY; Cheung OY; Ho WWS; Cheng KKF; Shing MMK; Ku DTL; Chung BHY; Yang W; Chan GCF; Ng HK; Liu APY
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
    Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
    J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
    Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
    Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review.
    Singh J; Sahu S; Mohan T; Mahajan S; Sharma MC; Sarkar C; Suri V
    Neurooncol Pract; 2023 Dec; 10(6):518-526. PubMed ID: 38009119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
    Pages M; Uro-Coste E; Colin C; Meyronet D; Gauchotte G; Maurage CA; Rousseau A; Godfraind C; Mokhtari K; Silva K; Figarella-Branger D; Varlet P; On Behalf Of The Renoclip-Loc Network
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
    Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
    Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
    von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.
    Kumar R; Liu APY; Orr BA; Northcott PA; Robinson GW
    Cancer; 2018 Nov; 124(21):4168-4180. PubMed ID: 30255939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
    Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
    Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Outcomes of CNS Tumors in Chinese Children: Comparative Analysis With the Surveillance, Epidemiology, and End Results Program.
    Liu APY; Liu Q; Shing MMK; Ku DTL; Fu E; Luk CW; Ling SC; Cheng KKF; Kwong DLW; Ho WWS; Ng HK; Gajjar A; Yasui Y; Chan GCF; Armstrong GT
    JCO Glob Oncol; 2020 May; 6():704-721. PubMed ID: 32392090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
    Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
    Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
    Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
    Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors.
    Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ
    J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of tumors of the central nervous system.
    Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
    Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
    Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
    Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
    Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
    Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
    Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
    Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methodological study of genome-wide DNA methylation analyses using matched archival formalin-fixed paraffin embedded and fresh frozen breast tumors.
    Espinal AC; Wang D; Yan L; Liu S; Tang L; Hu Q; Morrison CD; Ambrosone CB; Higgins MJ; Sucheston-Campbell LE
    Oncotarget; 2017 Feb; 8(9):14821-14829. PubMed ID: 28118602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
    Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
    Galbraith K; Vasudevaraja V; Serrano J; Shen G; Tran I; Abdallat N; Wen M; Patel S; Movahed-Ezazi M; Faustin A; Spino-Keeton M; Roberts LG; Maloku E; Drexler SA; Liechty BL; Pisapia D; Krasnozhen-Ratush O; Rosenblum M; Shroff S; Boué DR; Davidson C; Mao Q; Suchi M; North P; Hopp A; Segura A; Jarzembowski JA; Parsons L; Johnson MD; Mobley B; Samore W; McGuone D; Gopal PP; Canoll PD; Horbinski C; Fullmer JM; Farooqui MS; Gokden M; Wadhwani NR; Richardson TE; Umphlett M; Tsankova NM; DeWitt JC; Sen C; Placantonakis DG; Pacione D; Wisoff JH; Teresa Hidalgo E; Harter D; William CM; Cordova C; Kurz SC; Barbaro M; Orringer DA; Karajannis MA; Sulman EP; Gardner SL; Zagzag D; Tsirigos A; Allen JC; Golfinos JG; Snuderl M
    Neurooncol Adv; 2023; 5(1):vdad076. PubMed ID: 37476329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.